Cupid Limited shares reached a fresh peak of ₹231 following a 672% climb over the past year. The company raised its full-year FY27 revenue target to ₹660 crore, fueled by global exports and a new, diversified product lineup.
Detailed Coverage
Cupid Limited shares reached an intraday high of ₹231 on the BSE, continuing a strong performance trend that has seen the stock rise significantly over the last 12 months. This market movement follows the company's recent reclassification to the BSE Group ‘A’ category, which often indicates higher trading liquidity and regulatory compliance for investors.
Revenue Growth and FY27 Outlook
The company has set an ambitious financial target, projecting revenue of over ₹150 crore for the first quarter of the 2026-27 financial year. Based on this start, management has increased its total revenue guidance for the full fiscal year by at least 10%, now aiming for ₹660 crore. This upward revision reflects confidence in the company’s ability to scale its operations across its existing and newer business lines.
Diversification and Global Strategy
Historically known for manufacturing condoms and personal lubricants, Cupid has been working to reduce its reliance on a single product category. The company has expanded into the broader fast-moving consumer goods (FMCG) segment, introducing fragrances, face washes, and hair oils. This shift toward a more varied product portfolio is intended to create multiple streams of income and reach a wider consumer base in both domestic and international markets.
Cupid’s international footprint remains a core pillar of its business model, with products currently supplied to more than 125 countries. The company has secured long-term procurement contracts with major global entities, including the World Health Organization, the United Nations Population Fund, and the Partnership for Supply Chain Management. These agreements provide a level of demand stability that is less common in retail-focused consumer products, helping the company maintain consistent export volumes.
Investor Monitorables
While the expansion into FMCG and wellness items offers potential for growth, it also introduces new challenges. The consumer goods sector is highly competitive, and the company will need to manage marketing costs and distribution reach to gain a foothold against larger, established peers. Investors may track how effectively the company executes this transition without impacting its operating margins. Additionally, since a significant portion of revenue is tied to international health organization contracts, the company's ability to maintain these long-term agreements and manage global supply chain risks will be important for future performance. Shareholders should watch for the actual Q1 financial results to see if the reported revenue growth aligns with the management’s internal projections.